Company Filing History:
2 out of 1,929 
1 out of 3,687 
Years Active: 2008
Title: Narasimha N Murthy: Innovator in Nucleic Acid Research
Introduction
Narasimha N Murthy is a distinguished inventor based in Madras, India. He has made significant contributions to the field of nucleic acid research, particularly in the development of innovative methods for cancer treatment. With a total of 2 patents, his work has the potential to impact medical science profoundly.
Latest Patents
Murthy's latest patents include a dinuclear copper-based compound and ligand for nucleic acid scission and anticancer treatment. This invention relates to a novel method for oxidizing or splitting nucleic acids at specific points on a complementary nucleic acid segment using a dinuclear copper-based compound of Formula I. Additionally, it presents a new treatment for cancer, tumors, and cancer cells utilizing this compound or a naked ligand of Formula II.
Career Highlights
Throughout his career, Narasimha N Murthy has worked with prestigious institutions, including the University System of Maryland and The Johns Hopkins University. His research has focused on innovative approaches to address critical challenges in cancer treatment.
Collaborations
Murthy has collaborated with notable colleagues such as Steven E Rokita and Kenneth D Karlin, further enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Narasimha N Murthy's contributions to nucleic acid research and cancer treatment exemplify the spirit of innovation in science. His patents reflect a commitment to advancing medical knowledge and improving patient outcomes.